• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺癌中与细胞死亡相关基因的免疫基因组基因特征及其预后意义

Immunogenomic Gene Signature of Cell-Death Associated Genes with Prognostic Implications in Lung Cancer.

作者信息

Ahluwalia Pankaj, Ahluwalia Meenakshi, Mondal Ashis K, Sahajpal Nikhil, Kota Vamsi, Rojiani Mumtaz V, Rojiani Amyn M, Kolhe Ravindra

机构信息

Department of Pathology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.

Department of Medicine, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.

出版信息

Cancers (Basel). 2021 Jan 5;13(1):155. doi: 10.3390/cancers13010155.

DOI:10.3390/cancers13010155
PMID:33466402
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7795632/
Abstract

Lung cancer is one of the leading causes of death worldwide. Cell death pathways such as autophagy, apoptosis, and necrosis can provide useful clinical and immunological insights that can assist in the design of personalized therapeutics. In this study, variations in the expression of genes involved in cell death pathways and resulting infiltration of immune cells were explored in lung adenocarcinoma (The Cancer Genome Atlas: TCGA, lung adenocarcinoma (LUAD), 510 patients). Firstly, genes involved in autophagy ( = 34 genes), apoptosis ( = 66 genes), and necrosis ( = 32 genes) were analyzed to assess the prognostic significance in lung cancer. The significant genes were used to develop the cell death index (CDI) of 21 genes which clustered patients based on high risk (high CDI) and low risk (low CDI). The survival analysis using the Kaplan-Meier curve differentiated patients based on overall survival (40.4 months vs. 76.2 months), progression-free survival (26.2 months vs. 48.6 months), and disease-free survival (62.2 months vs. 158.2 months) (Log-rank test, < 0.01). Cox proportional hazard model significantly associated patients in high CDI group with a higher risk of mortality (Hazard Ratio: H.R 1.75, 95% CI: 1.28-2.45, < 0.001). Differential gene expression analysis using principal component analysis (PCA) identified genes with the highest fold change forming distinct clusters. To analyze the immune parameters in two risk groups, cytokines expression ( = 265 genes) analysis revealed the highest association of and (> 1.5-fold, < 0.01) with the high-risk group. The microenvironment cell-population (MCP)-counter algorithm identified the higher infiltration of CD8+ T cells, macrophages, and lower infiltration of neutrophils with the high-risk group. Interestingly, this group also showed a higher expression of immune checkpoint molecules , , and T cell exhaustion genes , , , , , and ) ( < 0.01). Furthermore, functional enrichment analysis identified significant perturbations in immune pathways in the higher risk group. This study highlights the presence of an immunocompromised microenvironment indicated by the higher infiltration of cytotoxic T cells along with the presence of checkpoint molecules and T cell exhaustion genes. These patients at higher risk might be more suitable to benefit from PD-L1 blockade or other checkpoint blockade immunotherapies.

摘要

肺癌是全球主要死因之一。自噬、凋亡和坏死等细胞死亡途径能提供有用的临床和免疫学见解,有助于设计个性化治疗方案。在本研究中,我们在肺腺癌中探索了细胞死亡途径相关基因表达的变化以及由此导致的免疫细胞浸润情况(癌症基因组图谱:TCGA,肺腺癌(LUAD),510例患者)。首先,分析了自噬相关基因(34个基因)、凋亡相关基因(66个基因)和坏死相关基因(32个基因),以评估其在肺癌中的预后意义。利用这些显著基因构建了一个由21个基因组成的细胞死亡指数(CDI),并据此将患者分为高风险(高CDI)和低风险(低CDI)两组。采用Kaplan-Meier曲线进行生存分析,结果显示两组患者在总生存期(40.4个月对76.2个月)、无进展生存期(26.2个月对48.6个月)和无病生存期(62.2个月对158.2个月)方面存在差异(对数秩检验,P<0.01)。Cox比例风险模型显示,高CDI组患者的死亡风险显著更高(风险比:HR 1.75,95%置信区间:1.28 - 2.45,P<0.001)。通过主成分分析(PCA)进行的差异基因表达分析确定了变化倍数最高的基因,这些基因形成了不同的聚类。为了分析两个风险组中的免疫参数,细胞因子表达(265个基因)分析显示,IL-1β和IL-6与高风险组的关联性最强(变化倍数>1.5,P<0.01)。微环境细胞群体(MCP)-计数器算法表明,高风险组中CD8 + T细胞和巨噬细胞浸润较高,中性粒细胞浸润较低。有趣的是,该组还显示出免疫检查点分子PD-L1、PD-L2和T细胞耗竭基因LAG-3、TIM-3、TIGIT、2B4、CD160和BTLA的表达较高(P<0.01)。此外,功能富集分析发现高风险组的免疫途径存在显著扰动。本研究强调了细胞毒性T细胞较高浸润以及检查点分子和T细胞耗竭基因的存在所表明的免疫功能低下微环境的存在。这些高风险患者可能更适合从PD-L1阻断或其他检查点阻断免疫疗法中获益。

相似文献

1
Immunogenomic Gene Signature of Cell-Death Associated Genes with Prognostic Implications in Lung Cancer.肺癌中与细胞死亡相关基因的免疫基因组基因特征及其预后意义
Cancers (Basel). 2021 Jan 5;13(1):155. doi: 10.3390/cancers13010155.
2
Immunogenomic Characteristics of Cell-Death-Associated Genes with Prognostic Implications in Bladder Cancer.免疫基因组学特征与膀胱癌预后相关的细胞死亡相关基因。
Front Immunol. 2022 Jul 11;13:909324. doi: 10.3389/fimmu.2022.909324. eCollection 2022.
3
Prognostic value and immune relevancy of a combined autophagy-, apoptosis- and necrosis-related gene signature in glioblastoma.胶质母细胞瘤中联合自噬、凋亡和坏死相关基因特征的预后价值及其免疫相关性。
BMC Cancer. 2022 Mar 3;22(1):233. doi: 10.1186/s12885-022-09328-3.
4
Leveraging diverse cell-death patterns to predict the clinical outcome of immune checkpoint therapy in lung adenocarcinoma: Based on muti-omics analysis and vitro assay.利用多种细胞死亡模式预测肺腺癌免疫检查点治疗的临床结局:基于多组学分析和体外检测。
Oncol Res. 2023 Dec 28;32(2):393-407. doi: 10.32604/or.2023.031134. eCollection 2023.
5
Bioinformatics analysis of BTK expression in lung adenocarcinoma: implications for immune infiltration, prognostic biomarkers, and therapeutic targeting.肺腺癌中BTK表达的生物信息学分析:对免疫浸润、预后生物标志物和治疗靶点的意义
3 Biotech. 2024 Sep;14(9):215. doi: 10.1007/s13205-024-04053-z. Epub 2024 Aug 28.
6
Deciphering a cell death-associated signature for predicting prognosis and response to immunotherapy in lung squamous cell carcinoma.解析与细胞死亡相关的特征,以预测肺鳞状细胞癌的预后和免疫治疗反应。
Respir Res. 2023 Jul 6;24(1):176. doi: 10.1186/s12931-023-02402-9.
7
Prognostic Cell Death Index for Lung Adenocarcinoma: A Comprehensive Transcriptome-Based Analysis of Twelve Programmed Cell Death Pattern Genes.肺腺癌预后细胞死亡指数:基于十二种程序性细胞死亡模式基因的综合转录组分析。
Front Biosci (Landmark Ed). 2024 Apr 1;29(4):135. doi: 10.31083/j.fbl2904135.
8
The prognostic value of immune escape-related genes in lung adenocarcinoma.免疫逃逸相关基因在肺腺癌中的预后价值
Transl Cancer Res. 2024 Jun 30;13(6):2647-2661. doi: 10.21037/tcr-23-2295. Epub 2024 Jun 25.
9
A signature-based classification of lung adenocarcinoma that stratifies tumor immunity.一种基于特征的肺腺癌分类方法,该方法对肿瘤免疫进行分层。
Front Oncol. 2023 Jan 12;12:1023833. doi: 10.3389/fonc.2022.1023833. eCollection 2022.
10
A Novel Necroptosis-Related lncRNA Signature Predicts the Prognosis of Lung Adenocarcinoma.一种新型坏死性凋亡相关lncRNA特征预测肺腺癌预后
Front Genet. 2022 Mar 17;13:862741. doi: 10.3389/fgene.2022.862741. eCollection 2022.

引用本文的文献

1
Growth Hormone Signaling in Bladder Cancer: Transcriptomic Profiling of Patient Samples and In Vitro Evidence of Therapy Resistance via ABC Transporters and EMT Activation.膀胱癌中的生长激素信号传导:患者样本的转录组分析及通过ABC转运蛋白和上皮-间质转化激活产生治疗抗性的体外证据
Int J Mol Sci. 2025 Jul 23;26(15):7113. doi: 10.3390/ijms26157113.
2
Identification of a TIGIT-expressing CD8 T cell subset as a potential prognostic biomarker in colorectal cancer.鉴定表达TIGIT的CD8 T细胞亚群作为结直肠癌潜在的预后生物标志物。
Front Immunol. 2025 Jul 29;16:1626367. doi: 10.3389/fimmu.2025.1626367. eCollection 2025.
3
The Current Roadmap of Lung Cancer Biology, Genomics and Racial Disparity.

本文引用的文献

1
Landscape of active enhancers developed de novo in cirrhosis and conserved in hepatocellular carcinoma.在肝硬化中重新形成并在肝细胞癌中保守存在的活跃增强子图谱。
Am J Cancer Res. 2020 Oct 1;10(10):3157-3178. eCollection 2020.
2
EIF2α phosphorylation: a hallmark of both autophagy and immunogenic cell death.真核生物起始因子2α磷酸化:自噬和免疫原性细胞死亡的一个标志
Mol Cell Oncol. 2020 Jun 19;7(5):1776570. doi: 10.1080/23723556.2020.1776570. eCollection 2020.
3
Unique TP53 neoantigen and the immune microenvironment in long-term survivors of Hepatocellular carcinoma.
肺癌生物学、基因组学与种族差异的当前路线图
Int J Mol Sci. 2025 Apr 17;26(8):3818. doi: 10.3390/ijms26083818.
4
Multi-cohort validation based on a novel prognostic signature of anoikis for predicting prognosis and immunotherapy response of esophageal squamous cell carcinoma.基于一种新的失巢凋亡预后特征的多队列验证,用于预测食管鳞状细胞癌的预后和免疫治疗反应。
Front Oncol. 2025 Mar 17;15:1530035. doi: 10.3389/fonc.2025.1530035. eCollection 2025.
5
Construction and validation of a cell death-related genes prognosis signature of hepatocellular carcinoma.肝细胞癌细胞死亡相关基因预后特征的构建与验证
Transl Cancer Res. 2025 Feb 28;14(2):1157-1170. doi: 10.21037/tcr-24-1315. Epub 2025 Feb 26.
6
Single cell transcriptomic analysis reveals tumor immune infiltration by macrophage cells gene signature in lung adenocarcinoma.单细胞转录组分析揭示了肺腺癌中巨噬细胞基因特征的肿瘤免疫浸润情况。
Discov Oncol. 2025 Mar 3;16(1):261. doi: 10.1007/s12672-025-01834-7.
7
Pan-cell death-related signature reveals tumor immune microenvironment and optimizes personalized therapy alternations in lung adenocarcinoma.Pan-cell 死亡相关特征揭示肺腺癌肿瘤免疫微环境并优化个体化治疗方案。
Sci Rep. 2024 Jul 8;14(1):15682. doi: 10.1038/s41598-024-66662-1.
8
Matrix metalloproteinase 9 expression and glioblastoma survival prediction using machine learning on digital pathological images.基于数字病理图像的机器学习对基质金属蛋白酶 9 表达和胶质母细胞瘤生存预测的研究。
Sci Rep. 2024 Jul 2;14(1):15065. doi: 10.1038/s41598-024-66105-x.
9
ANXA5: A Key Regulator of Immune Cell Infiltration in Hepatocellular Carcinoma.膜联蛋白 A5:调控肝癌免疫细胞浸润的关键分子。
Med Sci Monit. 2024 Jun 2;30:e943523. doi: 10.12659/MSM.943523.
10
New link between RNH1 and E2F1: regulates the development of lung adenocarcinoma.RNH1 与 E2F1 之间的新联系:调节肺腺癌的发展。
BMC Cancer. 2024 May 24;24(1):635. doi: 10.1186/s12885-024-12392-6.
肝癌长期生存者中独特的 TP53 新抗原和免疫微环境。
Cancer Immunol Immunother. 2021 Mar;70(3):667-677. doi: 10.1007/s00262-020-02711-8. Epub 2020 Sep 2.
4
Comprehensive molecular analyses of a TNF family-based signature with regard to prognosis, immune features, and biomarkers for immunotherapy in lung adenocarcinoma.基于 TNF 家族标志物的综合分子分析在肺腺癌中对预后、免疫特征和免疫治疗标志物的研究。
EBioMedicine. 2020 Sep;59:102959. doi: 10.1016/j.ebiom.2020.102959. Epub 2020 Aug 25.
5
High expression of immune checkpoints is associated with the TIL load, mutation rate and patient survival in colorectal cancer.免疫检查点的高表达与结直肠癌中的 TIL 负荷、突变率和患者生存相关。
Int J Oncol. 2020 Jul;57(1):237-248. doi: 10.3892/ijo.2020.5062. Epub 2020 May 8.
6
A new immune signature for survival prediction and immune checkpoint molecules in lung adenocarcinoma.肺腺癌中用于生存预测和免疫检查点分子的新型免疫特征。
J Transl Med. 2020 Mar 6;18(1):123. doi: 10.1186/s12967-020-02286-z.
7
T Cell Dysfunction and Exhaustion in Cancer.癌症中的T细胞功能障碍与耗竭
Front Cell Dev Biol. 2020 Feb 11;8:17. doi: 10.3389/fcell.2020.00017. eCollection 2020.
8
Utilizing gene expression profiles to characterize tumor infiltrating lymphocytes in cancers.利用基因表达谱来表征癌症中的肿瘤浸润淋巴细胞。
Ann Transl Med. 2019 Dec;7(Suppl 8):S289. doi: 10.21037/atm.2019.11.59.
9
Tumor Microenvironment.肿瘤微环境。
Medicina (Kaunas). 2019 Dec 30;56(1):15. doi: 10.3390/medicina56010015.
10
Immunological impact of cell death signaling driven by radiation on the tumor microenvironment.辐射诱导的细胞死亡信号对肿瘤微环境的免疫影响。
Nat Immunol. 2020 Feb;21(2):120-134. doi: 10.1038/s41590-019-0561-4. Epub 2019 Dec 23.